These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 16399595

  • 1. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
    Komanduri KV, Couriel D, Champlin RE.
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):1-6. PubMed ID: 16399595
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
    Marshall SR.
    Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
    [Abstract] [Full Text] [Related]

  • 8. Care for patients undergoing extracorporeal photopheresis to treat chronic graft-versus-host disease: review of the evidence.
    Woltz P, Castro K, Park BJ.
    Clin J Oncol Nurs; 2006 Dec; 10(6):795-802. PubMed ID: 17193945
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
    Kanold J, Merlin E, Halle P, Paillard C, Marabelle A, Rapatel C, Evrard B, Berger C, Stephan JL, Galambrun C, Piguet C, D'Incan M, Bordigoni P, Deméocq F.
    Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J, Serrano J, Gómez P, Martínez F, Martín C, Román-Gómez J, Rodríguez A, Herrera C, García JM, Alvarez MA, Torres A.
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [Abstract] [Full Text] [Related]

  • 14. Chronic graft-versus-host disease: clinical manifestation and therapy.
    Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP.
    Bone Marrow Transplant; 2001 Jul; 28(2):121-9. PubMed ID: 11509929
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, Todisco E, Rahal D, Migliavacca M, Longoni D, Solinas G, Villa A, Berti E, Mina PD, Parma M, Allavena P, Biagi E, Rovelli A, Biondi A, D'Amico G.
    Transplantation; 2009 Dec 15; 88(11):1261-72. PubMed ID: 19996925
    [Abstract] [Full Text] [Related]

  • 16. Graft-versus-host disease in allogeneic bone marrow transplantation: the role of monoclonal antibodies in prevention and treatment.
    Hiscott A, McLellan DS.
    Br J Biomed Sci; 2000 Dec 15; 57(2):163-9. PubMed ID: 10912294
    [Abstract] [Full Text] [Related]

  • 17. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?
    Har-Noy M, Slavin S.
    Med Hypotheses; 2008 Dec 15; 70(6):1186-92. PubMed ID: 18054441
    [Abstract] [Full Text] [Related]

  • 18. Recent compounds for immunosuppression and experimental therapies for acute graft-versus-host disease.
    Michael M, Shimoni A, Nagler A.
    Isr Med Assoc J; 2013 Jan 15; 15(1):44-50. PubMed ID: 23484241
    [Abstract] [Full Text] [Related]

  • 19. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C, Renoldi G, Parma M, Balduzzi A, Perseghin P, Biondi A.
    Transplantation; 2007 Jul 15; 84(1):31-9. PubMed ID: 17627234
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.